ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko05200	Pathways in cancer	12/27	492/7206	6.07265848413e-08
ko05224	Breast cancer	7/27	174/7206	2.50521390821e-06
ko05206	MicroRNAs in cancer	7/27	177/7206	2.80871858542e-06
ko05217	Basal cell carcinoma	5/27	68/7206	4.43142028512e-06
ko04310	Wnt signaling pathway	6/27	181/7206	4.40955049483e-05
ko04150	mTOR signaling pathway	6/27	184/7206	4.83647724832e-05
ko05166	HTLV-I infection	7/27	292/7206	7.36584679021e-05
ko04916	Melanogenesis	5/27	142/7206	0.000157606429416
ko04550	Signaling pathways regulating pluripotency of stem cells	5/27	165/7206	0.000317892153649
ko05205	Proteoglycans in cancer	6/27	271/7206	0.000406485860932
ko04390	Hippo signaling pathway	5/27	188/7206	0.000579806452681
ko05202	Transcriptional misregulation in cancer	5/27	188/7206	0.000579806452681
ko04072	Phospholipase D signaling pathway	5/27	197/7206	0.000717558674704
ko05418	Fluid shear stress and atherosclerosis	4/27	173/7206	0.00365656018528
ko05100	Bacterial invasion of epithelial cells	3/27	99/7206	0.00579218713484
ko05215	Prostate cancer	3/27	111/7206	0.00795055119606
ko04360	Axon guidance	4/27	233/7206	0.0104134461139
ko04510	Focal adhesion	4/27	240/7206	0.0115232174004
ko04810	Regulation of actin cytoskeleton	4/27	264/7206	0.0159038729326
ko04670	Leukocyte transendothelial migration	3/27	151/7206	0.0182563233988
ko04015	Rap1 signaling pathway	4/27	278/7206	0.0188901144365
ko04330	Notch signaling pathway	2/27	62/7206	0.022268219954
ko04060	Cytokine-cytokine receptor interaction	3/27	191/7206	0.0336087440405
ko05214	Glioma	2/27	79/7206	0.0348988816964
ko04062	Chemokine signaling pathway	3/27	201/7206	0.0382443503907
ko05218	Melanoma	2/27	85/7206	0.039888402854
ko04658	Th1 and Th2 cell differentiation	2/27	96/7206	0.0496901451412